Recludix Pharma
San Diego
About Recludix Pharma
Recludix pharma is a developing platform to discover potent and selective inhibitors of challenging protein targets. The platform approach integrates custom generated DNA-encoded libraries, massively parallel determination of structure-activity relationships, and a proprietary screening tool to ensure selectivity.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $60.0M
- Last round: Undisclosed (Jan 2026)
- Website: recludixpharma.com
- Phone: +1-858-258-5445
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/recludix-pharma-64872 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.